CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award Director acquired 5,814 shares (grant or award)
- 4 Grant or award Director acquired 2,325,581 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,000 shares (grant or award)
- 4 Shares withheld for taxes Sr. VP, Chief Business Officer gave up 3,969 shares (to pay taxes)
- 4 Open-market buy Director bought 37,700 shares at an average $6.91 ($260,457)
- 4 Open-market buy President and CEO bought 10,000 shares at $7.12 ($71,200)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 4,622 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 3,081,664 shares (grant or award)
- 4 Grant or award Director acquired 770,416 shares (grant or award)
- 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 7,312 shares (grant or award)
- 4 Grant or award Director acquired 9,140 shares (grant or award)
- 4 Grant or award Director acquired 5,027 shares (grant or award)
Page 20 of 29 · 564 filings